Literature DB >> 9769341

Proton MR spectroscopy of pediatric brain tumors.

J S Taylor1, R J Ogg, J W Langston.   

Abstract

Primary central nervous system tumors are the most common solid tumors in children. Their overall frequency is second only to that of leukemia. Many brain tumors in children are relatively benign and can be successfully treated with surgery or radiation therapy, but progress in treating the malignant forms of these neoplasms lags behind that for leukemias and other solid tumors. This article discusses how MR spectroscopy is used to manage the individualized treatment of children with brain tumors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9769341

Source DB:  PubMed          Journal:  Neuroimaging Clin N Am        ISSN: 1052-5149            Impact factor:   2.264


  6 in total

Review 1.  Advances in the assessment of childhood brain tumors and treatment-related sequelae.

Authors:  Katherine E Warren
Journal:  Curr Neurol Neurosci Rep       Date:  2005-03       Impact factor: 5.081

2.  Abnormally high levels of brain N-acetylaspartate in children with sickle cell disease.

Authors:  R Grant Steen; Robert J Ogg
Journal:  AJNR Am J Neuroradiol       Date:  2005-03       Impact factor: 3.825

3.  Proton MRS imaging in pediatric brain tumors.

Authors:  Maria Zarifi; A Aria Tzika
Journal:  Pediatr Radiol       Date:  2016-05-27

4.  Longitudinal MR spectroscopic imaging of pediatric diffuse pontine tumors to assess tumor aggression and progression.

Authors:  S B Thakur; S Karimi; I J Dunkel; J A Koutcher; W Huang
Journal:  AJNR Am J Neuroradiol       Date:  2006-04       Impact factor: 3.825

5.  Magnetic resonance spectroscopy in pediatric neuroradiology: clinical and research applications.

Authors:  Ashok Panigrahy; Marvin D Nelson; Stefan Blüml
Journal:  Pediatr Radiol       Date:  2009-11-24

Review 6.  MR spectroscopy in pediatric neuroradiology.

Authors:  Roberto Liserre; Lorenzo Pinelli; Roberto Gasparotti
Journal:  Transl Pediatr       Date:  2021-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.